Publications

Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013.

Morris, U; Xu, W; Msellem, MI; Schwartz, A; Abass, A; Shakely, D; COOK, J; Bhattarai, A; Petzold, M; Greenhouse, B; Ali, AS; Björkman, A; Fröberg, G; Mårtensson, A;

2015

Infection, genetics and evolution, (2015).33, 10.1016/j.meegid.2015.04.018.

Keeping ahead of the resistance curve: product bundling to conserve artemisinin-based combination therapy.

DAR, OA; Rokadiya, S; HEYMANN, DL;

2015

The Lancet Global health, (2015).3 6 10.1016/S2214-109X(15)70018-5.

Implementation of the integrated management of childhood illness with parasitological diagnosis of malaria in rural Ghana: health worker perceptions.

Febir, LG; BAIDEN, FE; Agula, J; Delimini, RK; Akpalu, B; Tivura, M; Amanfo, N; CHANDRAMOHAN, D; OWUSU-AGYEI, S; WEBSTER, J;

2015

Malaria journal, (2015).14 1 10.1186/s12936-015-0699-y.

Heritability of attractiveness to mosquitoes.

Fernández-Grandon, GM; Gezan, SA; Armour, JA L; Pickett, JA; LOGAN, JG;

2015

PloS one, (2015).10 4 10.1371/journal.pone.0122716.

Outdoor biting by Anopheles mosquitoes on Bioko Island does not currently impact on malaria control.

BRADLEY, J; LINES, J; Fuseini, G; Schwabe, C; Monti, F; Slotman, M; Vargas, D; Garcia, G; Hergott, D; KLEINSCHMIDT, I;

2015

Malaria journal, (2015).14 1 10.1186/s12936-015-0679-2.

Substandard antimalarials available in Afghanistan: a case for assessing the quality of drugs in resource poor settings.

LALANI, M; KAUR, H; Mohammed, N; Mailk, N; Wyk, AV; Jan, S; Kakar, RM; Mojadidi, MK; LESLIE, T;

2015

The American journal of tropical medicine and hygiene, (2015).92 6 Supp 10.4269/ajtmh.14-0394.

Monthly malaria chemoprevention shows potential in an area of very high, perennial malaria transmission.

CAIRNS, M; Walker, PG T;

2015

Evidence-based medicine, (2015).20 3 10.1136/ebmed-2015-110173.

Clinical, geographical, and temporal risk factors associated with presentation and outcome of vivax malaria imported into the United Kingdom over 27 years: observational study.

Broderick, C; NADJM, B; Smith, V; BLAZE, M; Checkley, A; CHIODINI, PL; WHITTY, CJ M;

2015

BMJ (Clinical research ed), (2015).350 apr16 10.1136/bmj.h1703.

Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim® (dihydroartemisinin/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and Tanzania.

Baiden, R; Oduro, A; Halidou, T; Gyapong, M; Sie, A; Macete, E; Abdulla, S; OWUSU-AGYEI, S; Mulokozi, A; Adjei, A; Sevene, E; Compaoré, G; Valea, I; OSEI, I; Yawson, A; Adjuik, M; Akparibo, R; Ogutu, B; Upunda, GL; SMITH, P; Binka, F;

2015

Malaria journal, (2015).14 1 10.1186/s12936-015-0664-9.

Variation in Plasmodium falciparum erythrocyte invasion phenotypes and merozoite ligand gene expression across different populations in areas of malaria endemicity.

Bowyer, PW; STEWART, LB; ASPELING-JONES, H; Mensah-Brown, HE; Ahouidi, AD; AMAMBUA-NGWA, A; Awandare, GA; CONWAY, DJ;

2015

Infection and immunity, (2015).83 6 10.1128/IAI.03009-14.